Shanghai Pharmaceuticals Holding Co.Ltd(601607) (SH Shanghai Pharmaceuticals Holding Co.Ltd(601607) , closing price: 24.42 yuan) released the annual performance report on March 29, saying that the operating revenue in 2021 was about 215824 billion yuan, a year-on-year increase of 12.46%; The net profit attributable to shareholders of listed companies was about 5.093 billion yuan, a year-on-year increase of 13.28%; The basic earnings per share was 1.79 yuan, a year-on-year increase of 13.28%. It is proposed to distribute a cash dividend of 4.2 yuan (including tax) for every 10 shares, no bonus shares and no increase.
From January to June 2021, Shanghai Pharmaceuticals Holding Co.Ltd(601607) the composition of operating revenue is: distribution accounts for 87.88%, industry accounts for 11.97%, retail accounts for 3.52%, others account for 0.22%, and internal offset accounts for – 3.93%.
the president of Shanghai Pharmaceuticals Holding Co.Ltd(601607) is Zuo min, male, 61 years old, with a master’s degree background.
